Latest Clinical pharmacology Stories
DAYTON, Ohio, Nov. 4, 2014 /PRNewswire/ -- Cornerstone Project, LLC.
-- Optimizes resources by leveraging shared-services -- HAYWARD, Calif., Oct.
Is the de novo process right for a particular medical device? To help manufacturers decide, FDAnews is pleased to present a 90-minute webinar on Nov.
The FDA's enforcement plan makes it clear: Developing a successful CAPA program has never been more important. FDAnews and Compliance Media, Inc.
UNION CITY, Calif., Oct. 23, 2014 /PRNewswire/ -- Abaxis, Inc.
The appropriate handling of inspections can affect the timing of approvals and may mean the difference in whether the agency takes a regulatory action or grants a product approval.
Lawrence Livermore National Laboratory researchers recently published an article in PLOS ONE detailing the use of supercomputers to link proteins to drug side effects.
On October 10, the FDA announced that certain unexpired human and veterinary sterile products by Oregon Compounding Centers, Inc. are recalled due to lack of sterility assurance.
LONDON, Oct. 15. 30, 2014 /PRNewswire/ -- REPORT HIGHLIGHTS The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.